Modafinil is a wakefulness-promoting agent that was developed in France in the 1970s and introduced into clinical use in the 1990s. It was originally designed to treat sleep disorders such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea–related excessive daytime sleepiness. Unlike antiretroviral drugs such as abacavir, modafinil acts on the central nervous system to enhance alertness and cognitive function, although its exact mechanism is not fully understood. Its development marked an important advancement in the management of sleep disorders, offering a lower risk of dependence compared to traditional stimulants like amphetamines. Over time, it has also been studied for off-label uses including fatigue associated with various medical conditions and cognitive enhancement, though such uses require careful medical supervision.
BRAND NAMES
Provigil (most widely recognized brand)
Modalert
Modvigil
Alertec
Vigicer
MECHANISM OF ACTION
Modafinil promotes wakefulness primarily by acting on the central nervous system, although its exact mechanism is not completely understood. It inhibits the reuptake of dopamine by blocking the dopamine transporter, thereby increasing dopamine levels in the brain, which contributes to enhanced alertness and wakefulness.
PHARMACOKINETICS:
Absorption
Modafinil is well absorbed after oral administration, with a bioavailability of approximately 80%. Peak plasma concentrations are usually reached within 2 to 4 hours. Food may slightly delay absorption but does not significantly affect overall bioavailability.
Distribution
Modafinil is moderately distributed in body tissues, with an apparent volume of distribution of about 0.9 L/kg. It is highly bound to plasma proteins (around 60%), mainly albumin, which may influence drug interactions with other highly protein-bound medications.
Metabolism
Modafinil is extensively metabolized in the liver, primarily via amide hydrolysis and cytochrome P450 (CYP3A4)–mediated pathways, producing inactive metabolites such as modafinil acid and modafinil sulfone. It also induces CYP3A4 and may inhibit CYP2C19, affecting the metabolism of other drugs.
Elimination
The drug and its metabolites are mainly eliminated through the kidneys, with approximately 80–90% of the dose recovered in urine as metabolites. The elimination half-life ranges from about 12 to 15 hours, allowing once-daily dosing in most indications.
PHARMACODYNAMICS
Modafinil is a wakefulness-promoting agent whose exact mechanism is not fully defined but is primarily linked to effects on multiple neurotransmitter systems in the central nervous system. It increases dopamine levels by inhibiting dopamine reuptake through blockade of the dopamine transporter, enhancing alertness and reducing sleepiness.
ADMINISTRATION
Modafinil is administered orally in tablet form, typically once daily in the morning. It is usually taken in doses of 100 mg to 200 mg, depending on the indication such as narcolepsy, obstructive sleep apnea–related sleepiness, or shift work sleep disorder. The tablet can be taken with or without food, although taking it with food may slightly delay the onset of action.
DOSAGE AND STRENGTH
Modafinil is available in tablet form, commonly in strengths of 100 mg and 200 mg. The usual adult dose depends on the condition being treated, with most patients receiving 200 mg once daily in the morning for narcolepsy or excessive daytime sleepiness associated with obstructive sleep apnea. For shift work sleep disorder, it is typically taken as 200 mg about one hour before the start of the work shift.
DRUG INTERACTIONS
Modafinil has several important drug interactions mainly because it affects liver enzymes (it induces CYP3A4 and inhibits CYP2C19), which can change how other medicines are processed in the body. One of the most clinically significant interactions is with hormonal contraceptives (such as pills, patches, and implants), where modafinil can reduce their effectiveness and increase the risk of unintended pregnancy, so backup non-hormonal contraception is recommended during use and for some time after stopping.
FOOD INTERACTIONS
Modafinil has relatively few significant food interactions, and it can generally be taken with or without food without major changes in effectiveness. However, taking it with a high-fat meal may delay how quickly it starts working, even though the overall amount absorbed into the body remains largely the same.
CONTRAINDICATIONS
Modafinil is contraindicated in a few key situations where its use can be unsafe or not recommended. The most important absolute contraindication is a known hypersensitivity or allergic reaction to modafinil or armodafinil, including serious skin reactions such as Stevens–Johnson syndrome or drug rash with eosinophilia and systemic symptoms (DRESS).
SIDE EFFECTS
Headache
Nausea
Dry mouth
Loss of appetite
Nervousness or anxiety
Insomnia (difficulty sleeping)
Dizziness
Diarrhea or stomach discomfort
OVER DOSAGE
Modafinil overdose occurs when a person takes more than the recommended dose, leading to exaggerated stimulant effects on the brain and cardiovascular system. Symptoms typically include severe insomnia, restlessness, anxiety, agitation, headache, dizziness, tremors, and confusion.
TOXICITY
Modafinil toxicity is uncommon but can occur with excessive dosing, drug interactions, or use in sensitive individuals. It mainly affects the central nervous system, cardiovascular system, and mental state. Neurologically, toxicity may cause severe agitation, confusion, tremors, intense insomnia, headaches, and in rare cases seizures.
